Tamura M, Kawano T
Acta Paediatr Jpn. 1989 Dec;31(6):734-41. doi: 10.1111/j.1442-200x.1989.tb01388.x.
We performed sequential measurements of pulmonary mechanics following instillation of reconstituted bovine surfactant (surfactant TA) in 10 neonates with severe respiratory distress syndrome. The respiratory compliance did not increase significantly until six hours after surfactant administration, while the arterial oxygenation and radiographic appearance improved rapidly after surfactant therapy. Six infants developed clinically significant PDA between 24 hours and 48 hours after surfactant therapy, when the compliance decreased temporarily after initial improvement until the PDA was closed pharmacologically. In six cases airway resistance rose transiently following surfactant treatment, whereas PCO2 fell significantly in all cases by six hours after surfactant administration. We recommend that only inspired oxygen concentration should be adjusted without changing the pressure setting of a respirator for at least three hours after surfactant therapy.
我们对10例患有严重呼吸窘迫综合征的新生儿在滴注重组牛肺表面活性物质(表面活性物质TA)后进行了肺力学的连续测量。在给予表面活性物质后6小时,呼吸顺应性才显著增加,而表面活性物质治疗后动脉氧合和影像学表现迅速改善。6例婴儿在表面活性物质治疗后24小时至48小时出现具有临床意义的动脉导管未闭,此时顺应性在最初改善后暂时下降,直至通过药物治疗使动脉导管未闭闭合。在6例病例中,表面活性物质治疗后气道阻力短暂升高,而在给予表面活性物质后6小时,所有病例的二氧化碳分压均显著下降。我们建议在表面活性物质治疗后至少3小时内,仅调整吸入氧浓度,而不改变呼吸机的压力设置。